According to SGX, SDAV surged amid robust activity from the corporate earnings season and the quarterly rebalancing by the MSCI. The benchmark Straits Times Index (STI) was up by 1.3% to 3,336.59 points.
Derivatives traded volume rose by 17% y-o-y but fell by 1% m-o-m to 23.9 million contracts while derivatives daily average volume (DDAV) was up by 16% y-o-y but fell by 4% m-o-m to 1.1 million contracts.
“Our current forecasts assume 2HFY2024 SDAV [to be at] $1.15 billion and DDAV at 1.16 million. Our FY2024 earnings are 3% ahead of consensus,” Tan writes in his June 7 (US Eastern time) report.
In comparison, SGX’s SDAV for the first five months this year came at a cumulative $1.169 billion while DDAV stood at 1.17 million contracts.
See also: SAC Capital initiates ‘buy’ on Sanli Environmental after $105.3 mil contract win from PUB
While the consensus currently expects SGX’s revenue – excluding cash equities – to be 5% higher on a h-o-h basis, Tan expects analysts to increase their earnings estimates towards SGX’s FY2024 earnings due August.
“[The] recent recovery in turnover, we believe are not yet factored in by the street, and could lead to upside earnings surprise,” says Tan.
“SGX’s strategic priorities are growth and diversification. In our view, potential measures that could boost trading liquidity on SGX and provide further positive catalysts, include creating tech ecosystem by removing profitability criteria for initial public offerings (IPOs), incentivising assets under management (AUM) to invest more in Singapore (versus current 88% invested overseas) and sovereign funds creating additional liquidity pool,” he adds.
Shares in SGX closed 7 cents lower or 0.72% down at $9.60 on June 10.
